Article Details

Gilead Stock – Gilead cuts 2020 sales outlook as COVID-19 drug remdesivir falls short

Retrieved on: 2021-06-20 17:48:45

Tags for this article:

Click the tags to see associated articles and topics

Gilead Stock – Gilead cuts 2020 sales outlook as COVID-19 drug remdesivir falls short. View article details on hiswai:

Excerpt

O on Wednesday cut its 2020 revenue forecast, citing lower-than-expected demand and difficulty in predicting sales of remdesivir, the only treatment ...

Article found on: fintechzoom.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up